Clinical and Economic Issues in the Treatment of Advanced Breast Cancer with Bisphosphonates

ISSN： 1170-229X

Source： Drugs & Aging, Vol.20, Iss.9, 2003-01, pp. : 631-642

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bisphosphonates get a break in advanced breast cancer

Inpharma, Vol. 1, Iss. 1272, 2001-01 ,pp. : 6-7

Adis International

Access to resources Recommend Favorite

The Role of Bisphosphonates in Breast Cancer

By Theriault Richard L.

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 1, Iss. 2, 2003-04 ,pp. : 232-241

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

The Treatment of Advanced Prostate Cancer with Ketoconazole: Safety Issues

By Bok R.A. Small E.J.

Drug Safety, Vol. 20, Iss. 5, 1999-05 ,pp. : 451-458

Adis International

Access to resources Recommend Favorite

Experience with Exemestane in the Treatment of Early and Advanced Breast Cancer

By Lønning Per Eystein Geisler Jürgen

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 7, 2008-07 ,pp. : 987-997

Informa Healthcare

Access to resources Recommend Favorite

The Clinical and Cost Considerations of Bisphosphonates in Preventing Bone Complications in Patients with Metastatic Breast Cancer or Multiple Myeloma

By McCloskey E.V.

Drugs, Vol. 61, Iss. 9, 2001-01 ,pp. : 1253-1274

Adis International

Access to resources Recommend Favorite